Therapeutic Research Center Acquired by Levine Leichtman Capital Partners

Press Release

 | September 6, 2017

Choate recently advised certain investors in connection with the acquisition of Therapeutic Research Center (TRC) by Levine Leichtman Capital Partners from Francisco Partners and management. Previously, Choate represented TRC in connection with Francisco Partners’ strategic investment in the company.

TRC, of Stockton, California, provides medication advisory and learning solutions for pharmacists, pharmacy technicians, prescribers, nurses and other clinicians to enable to delivery of better, safer and more effective patient care.

The Choate team included partners Christian Atwood (private equity), Andrew Hickey (finance), and Tim Becker (tax).


Thank you for reaching out to contact Choate. Before you send your message, we wanted to make sure you are aware of the following. Please do not send any confidential information in response to this link. Sending an e-mail to Choate does not give rise to an attorney-client relationship, and will not be deemed to disqualify Choate from undertaking any engagement for a current or future client.  Before any attorney-client engagement may be formed, Choate will need to check for possible conflicts of interest, you will need to consider whether you wish to retain Choate as counsel, and we will need to consider whether we wish to accept the potential engagement. In the meantime, Choate reserves the right to represent parties with interests adverse to you.